Reports
Sale
Global Rapid Infuser Market Size, Share, Analysis, Forecast: By Type: Trolley Mounted Devices, Handheld Devices; By Usability: Single Use, Reusable; By Applications: Cancer, Diabetes, Pediatric, Others; By End Users: Hospitals, Ambulatory Services, Specialty Clinics, Others; Regional Analysis; Supplier Landscape; 2024-2032
Global Rapid Infuser Market Outlook
The global rapid infuser market size was valued at USD 987.7 million in 2023, driven by the increasing cases of hypothermia globally. The market size is anticipated to grow at a CAGR of 4.2% during the forecast period of 2024-2032 to achieve a value of USD 1429.9 million by 2032.
Global Rapid Infuser Market Overview
Rapid infusers are used to warm liquids in emergency medical conditions and surgeries such as haemorrhage. The rapid infuser system may continuously administer human bodily fluid in a slow to quick flow. It is typically used in emergencies to provide effective and safe therapy to patients who are suffering from severe blood loss or hypovolemic shock. There are two types of rapid infuser devices, some of them are powered by a compressor while others are connected to hospital wall-pressured outlets.
The increasing cases of hypothermia, chronic pulmonary diseases, and surgical site infections are directly contributing to the rapid infuser market growth. Rapid infusers are the most convenient and efficient means of providing bodily fluids to patients in an instant. Hence, they are extensively used in anaesthetic centres as a treatment alternative. The demand for rapid infusers is also increasing with the number of ambulatory healthcare facilities. As accident cases are rising, they directly fuel the market demand.
The market is further driven by the rising research activities to improve the efficacy of rapid infusers. There is a growing integration of advanced technologies, expected to propel the market expansion. The market may also be influenced by increased competition among companies providing devices with enhanced features that minimize negative effects on blood components.
Surge in FDA Approvals to Meet the Rising Rapid Infuser Market Demand
In August, 2023, ICU Medical Inc., a worldwide leader in the development, manufacture, and sale of innovative medical devices, announced that the company has received 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) for the Plum Duo infusion pump with LifeShield infusion safety software. The Plum Duo pump and LifeShield software will be made available to customers in the United States by early 2024.
This approval marks a significant milestone for ICU Medical Inc. and exhibits their dedication to providing safe and advanced medical devices. The market is expected to be bolstered by this FDA approval as it will provide healthcare professionals with a technologically advanced and safe solution in the form of the Plum Duo infusion pump, along with an additional layer of safety with LifeShield infusion safety software.
Innovative Product Launches to Boost the Rapid Infuser Market Share
In April 2023, Eitan Medical, a global leader in advanced infusion therapy and drug delivery solutions with reliable innovations, announced the launch of its new cutting-edge connected infusion multi-therapy ambulatory infusion system – Avoset™. It is designed to transform post-acute care and specialty infusion therapy with compact and simplified technology that can monitor infusion treatment data remotely, aiming to enhance patient safety and improve the user experience.
The Avoset™ Infusion Platform complements the Sapphire Infusion portfolio and is especially well positioned to address infusion needs for therapies that require secure medication reservoirs and a long battery life at low flow rates. The Avoset Infusion Pump is MDR certified and is currently available in selected European countries. The major offering of the product is its ability to monitor infusion treatment data remotely, allowing healthcare professionals to keep track of patient progress and enhance it. This will result in increased adoption of the system by healthcare professionals in clinical settings, contributing to the increased demand, and propelling the rapid infuser market size.
Additionally, in January 2024, Switzerland-based medical devices maker PharmaSens applied for US Food and Drug Administration (FDA) for its ‘niia essential’ insulin patch pump system. It is a significant move for PharmaSens as it is an advancing insulin pump technology, also claimed to be one of the most compact patch pumps available. It incorporates an automatic needle insertion mechanism, ensuring the safety of the 90° steel needle. The semi-reusable concept of the insulin pump system aligns with cost-efficiency and sustainable design, meeting the demand for environmentally friendly products. These features could be the major reason for the increased adoption of this system in the forecast period.
Global Rapid Infuser Market Segmentation
Market Breakup by Type
- Trolley Mounted Devices
- Handheld Devices
Market Breakup by Usability
- Single Use
- Reusable
Market Breakup by Applications
- Cancer
- Diabetes
- Pediatric
- Others
Market Breakup by End Users
- Hospitals
- Ambulatory Services
- Specialty Clinics
- Others
Market Breakup by Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Global Rapid Infuser Market Regional Analysis
Geographically, North America is leading the global market rapid infuser market share and is expected to lead throughout the forecast period. This is due to access to advanced and innovative technologies associated with healthcare and effective healthcare regulations, contributing to the market growth in the region.
In November 2023, 410 Medical, Inc., focused on early resuscitation of emergency patients with shock and hypotension, announced the completion of an Air Force AFWERX Phase II SBIR Award to advance the development of LifeFlow Ultra. This innovative ultra-compact rapid infuser is designed for operational environments where space, weight, and power supply are at an absolute premium. Like the currently marketed LifeFlow PLUS, LifeFlow Ultra will enable healthcare providers to transfuse blood and IV fluids quickly for patients with hemorrhagic shock.
By promising efficiency in transfusing blood and IV fluids quickly for patients experiencing hemorrhagic shock LifeFlow Ultra has positioned itself among the key players in the market. This offering also makes them stand out as a valuable addition to the existing market, boosting the global rapid infuser market value.
Global Rapid Infuser Market: Competitor Landscape
In July 2023, BD (Becton, Dickinson and Company), a leading global medical technology company, announced that the updated BD Alaris™ Infusion System received 510(k) clearance from the U.S. Food and Drug Administration (FDA), which enables both remediation and a return to full commercial operations for the most comprehensive infusion system available in the United States.
This clearance covers updated hardware features for Point-of-Care Unit (PCU), large volume pumps, syringe pumps, patient-controlled analgesia (PCA) pumps, respiratory monitoring, and auto-identification modules. It also covers a new BD Alaris™ Infusion System software version with enhanced cybersecurity, along with interoperability features that enable smart, connected care with the most widely used electronic medical record (EMR) systems.
The key features of the rapid infuser market report include patent analysis, grants analysis, funding and investment analysis, partnerships, and collaborations analysis by the leading key players. The major companies in the market are as follows:
- Becton, Dickinson and Company (BD)
- B. Braun Melsungen AG
- Smiths Medical (A division of Smiths Group)
- 3M Company
- Teleflex Incorporated
- Fresenius Kabi AG
- Stryker Corporation
- Smith Medical
- ZOLL Medical Corporation
- GE Healthcare
- Baxter International Inc.
- Halyard Health
- Ivenix, Inc.
- AngioDynamics, Inc.
- FiPerSys Medical
Kindly note that this only represents a partial list of companies, and the complete list has been provided in the report.
Key Highlights of the Report
| REPORT FEATURES | DETAILS |
| Base Year | 2023 |
| Historical Period | 2017-2023 |
| Forecast Period | 2024-2032 |
| Scope of the Report |
Historical and Forecast Trends, Industry Drivers and Constraints, Historical and Forecast Market Analysis by Segment:
|
| Breakup by Type |
|
| Breakup by Usability |
|
| Breakup by Applications |
|
| Breakup by End Users |
|
| Breakup by Region |
|
| Market Dynamics |
|
| Competitive Landscape |
|
| Companies Covered |
|
*At Expert Market Research, we strive to always give you current and accurate information. The numbers depicted in the description are indicative and may differ from the actual numbers in the final EMR report.
1 Preface
1.1 Objectives of the Study
1.2 Key Assumptions
1.3 Report Coverage – Key Segmentation and Scope
1.4 Research Methodology
2 Executive Summary
3 Global Rapid Infuser Market Overview
3.1 Global Rapid Infuser Market Historical Value (2017-2023)
3.2 Global Rapid Infuser Market Forecast Value (2024-2032)
4 Global Rapid Infuser Market Landscape
4.1 Global Rapid Infuser: Developers Landscape
4.1.1 Analysis by Year of Establishment
4.1.2 Analysis by Company Size
4.1.3 Analysis by Region
4.2 Global Rapid Infuser: Product Landscape
4.2.1 Analysis by Type
4.2.2 Analysis by Applications
5 Global Rapid Infuser Market Dynamics
5.1 Market Drivers and Constraints
5.2 SWOT Analysis
5.2.1 Strengths
5.2.2 Weaknesses
5.2.3 Opportunities
5.2.4 Threats
5.3 Porter’s Five Forces Model
5.3.1 Bargaining Power of Suppliers
5.3.2 Bargaining Power of Buyers
5.3.3 Threat of New Entrants
5.3.4 Threat of Substitutes
5.3.5 Degree of Rivalry
5.4 Key Demand Indicators
5.5 Key Price Indicators
5.6 Industry Events, Initiatives, and Trends
5.7 Value Chain Analysis
6 Global Rapid Infuser Market Segmentation (2017-2032)
6.1 Global Rapid Infuser Market (2017-2032) by Type
6.1.1 Market Overview
6.1.2 Trolley Mounted Devices
6.1.3 Handheld Devices
6.2 Global Rapid Infuser Market (2017-2032) by Usability
6.2.1 Market Overview
6.2.2 Single Use
6.2.3 Reusable
6.3 Global Rapid Infuser Market (2017-2032) by Applications
6.3.1 Market Overview
6.3.2 Cancer
6.3.3 Diabetes
6.3.4 Pediatric
6.3.5 Others
6.4 Global Rapid Infuser Market (2017-2032) by End Users
6.4.1 Market Overview
6.4.2 Hospitals
6.4.3 Ambulatory Services
6.4.4 Specialty Clinics
6.4.5 Others
6.5 Global Rapid Infuser Market (2017-2032) by Region
6.5.1 Market Overview
6.5.2 North America
6.5.3 Europe
6.5.4 Asia Pacific
6.5.5 Latin America
6.5.6 Middle East and Africa
7 North America Rapid Infuser Market (2017-2032)
7.1 North America Rapid Infuser Market (2017-2032) by Type
7.1.1 Market Overview
7.1.2 Trolley Mounted Devices
7.1.3 Handheld Devices
7.2 North America Rapid Infuser Market (2017-2032) by Usability
7.2.1 Market Overview
7.2.2 Single Use
7.2.3 Reusable
7.3 North America Rapid Infuser Market (2017-2032) by Country
7.3.1 United States of America
7.3.2 Canada
8 Europe Rapid Infuser Market (2017-2032)
8.1 Europe Rapid Infuser Market (2017-2032) by Type
8.1.1 Market Overview
8.1.2 Trolley Mounted Devices
8.1.3 Handheld Devices
8.2 Europe Rapid Infuser Market (2017-2032) by Usability
8.2.1 Market Overview
8.2.2 Single Use
8.2.3 Reusable
8.3 Europe Rapid Infuser Market (2017-2032) by Country
8.3.1 United Kingdom
8.3.2 Germany
8.3.3 France
8.3.4 Italy
8.3.5 Others
9 Asia Pacific Rapid Infuser Market (2017-2032)
9.1 Asia Pacific Rapid Infuser Market (2017-2032) by Type
9.1.1 Market Overview
9.1.2 Trolley Mounted Devices
9.1.3 Handheld Devices
9.2 Asia Pacific Rapid Infuser Market (2017-2032) by Usability
9.2.1 Market Overview
9.2.2 Single Use
9.2.3 Reusable
9.3 Asia Pacific Rapid Infuser Market (2017-2032) by Country
9.3.1 China
9.3.2 Japan
9.3.3 India
9.3.4 ASEAN
9.3.5 Australia
9.3.6 Others
10 Latin America Rapid Infuser Market (2017-2032)
10.1 Latin America Rapid Infuser Market (2017-2032) by Type
10.1.1 Market Overview
10.1.2 Trolley Mounted Devices
10.1.3 Handheld Devices
10.2 Latin America Rapid Infuser Market (2017-2032) by Usability
10.2.1 Market Overview
10.2.2 Single Use
10.2.3 Reusable
10.3 Latin America Rapid Infuser Market (2017-2032) by Country
10.3.1 Brazil
10.3.2 Argentina
10.3.3 Mexico
10.3.4 Others
11 Middle East and Africa Rapid Infuser Market (2017-2032)
11.1 Middle East and Africa Rapid Infuser Market (2017-2032) by Type
11.1.1 Market Overview
11.1.2 Trolley Mounted Devices
11.1.3 Handheld Devices
11.2 Middle East and Africa Rapid Infuser Market (2017-2032) by Usability
11.2.1 Market Overview
11.2.2 Single Use
11.2.3 Reusable
11.3 Middle East and Africa Rapid Infuser Market (2017-2032) by Country
11.3.1 Saudi Arabia
11.3.2 United Arab Emirates
11.3.3 Nigeria
11.3.4 South Africa
11.3.5 Others
12 Regulatory Framework
12.1 Regulatory Overview
12.1.1 US FDA
12.1.2 EU EMA
12.1.3 INDIA CDSCO
12.1.4 JAPAN PMDA
12.1.5 Others
13 Patent Analysis
13.1 Analysis by Type of Patent
13.2 Analysis by Publication Year
13.3 Analysis by Issuing Authority
13.4 Analysis by Patent Age
13.5 Analysis by CPC Analysis
13.6 Analysis by Patent Valuation
13.7 Analysis by Key Players
14 Grants Analysis
14.1 Analysis by Year
14.2 Analysis by Amount Awarded
14.3 Analysis by Issuing Authority
14.4 Analysis by Grant Application
14.5 Analysis by Funding Institute
14.6 Analysis by NIH Departments
14.7 Analysis by Recipient Organization
15 Funding and Investment Analysis
15.1 Analysis by Funding Instances
15.2 Analysis by Type of Funding
15.3 Analysis by Funding Amount
15.4 Analysis by Leading Players
15.5 Analysis by Leading Investors
15.6 Analysis by Geography
16 Partnership and Collaborations Analysis
16.1 Analysis by Partnership Instances
16.2 Analysis by Type of Partnership
16.3 Analysis by Leading Players
16.4 Analysis by Geography
17 Supplier Landscape
17.1 Becton, Dickinson and Company (BD)
17.1.1 Financial Analysis
17.1.2 Product Portfolio
17.1.3 Demographic Reach and Achievements
17.1.4 Mergers and Acquisitions
17.1.5 Certifications
17.2 B. Braun SE
17.2.1 Financial Analysis
17.2.2 Product Portfolio
17.2.3 Demographic Reach and Achievements
17.2.4 Mergers and Acquisitions
17.2.5 Certifications
17.3 Smiths Group Plc.
17.3.1 Financial Analysis
17.3.2 Product Portfolio
17.3.3 Demographic Reach and Achievements
17.3.4 Mergers and Acquisitions
17.3.5 Certifications
17.4 3M
17.4.1 Financial Analysis
17.4.2 Product Portfolio
17.4.3 Demographic Reach and Achievements
17.4.4 Mergers and Acquisitions
17.4.5 Certifications
17.5 Teleflex Incorporated
17.5.1 Financial Analysis
17.5.2 Product Portfolio
17.5.3 Demographic Reach and Achievements
17.5.4 Mergers and Acquisitions
17.5.5 Certifications
17.6 Fresenius Kabi AG
17.6.1 Financial Analysis
17.6.2 Product Portfolio
17.6.3 Demographic Reach and Achievements
17.6.4 Mergers and Acquisitions
17.6.5 Certifications
17.7 Stryker Corporation
17.7.1 Financial Analysis
17.7.2 Product Portfolio
17.7.3 Demographic Reach and Achievements
17.7.4 Mergers and Acquisitions
17.7.5 Certifications
17.8 Biegler GmbH
17.8.1 Financial Analysis
17.8.2 Product Portfolio
17.8.3 Demographic Reach and Achievements
17.8.4 Mergers and Acquisitions
17.8.5 Certifications
17.9 ZOLL Medical Corporation
17.9.1 Financial Analysis
17.9.2 Product Portfolio
17.9.3 Demographic Reach and Achievements
17.9.4 Mergers and Acquisitions
17.9.5 Certifications
17.10 GE Healthcare
17.10.1 Financial Analysis
17.10.2 Product Portfolio
17.10.3 Demographic Reach and Achievements
17.10.4 Mergers and Acquisitions
17.10.5 Certifications
17.11 Baxter
17.11.1 Financial Analysis
17.11.2 Product Portfolio
17.11.3 Demographic Reach and Achievements
17.11.4 Mergers and Acquisitions
17.11.5 Certifications
17.12 Halyard Health
17.12.1 Financial Analysis
17.12.2 Product Portfolio
17.12.3 Demographic Reach and Achievements
17.12.4 Mergers and Acquisitions
17.12.5 Certifications
17.13 Fresenius Kabi AG
17.13.1 Financial Analysis
17.13.2 Product Portfolio
17.13.3 Demographic Reach and Achievements
17.13.4 Mergers and Acquisitions
17.13.5 Certifications
17.14 Angio Dynamics
17.14.1 Financial Analysis
17.14.2 Product Portfolio
17.14.3 Demographic Reach and Achievements
17.14.4 Mergers and Acquisitions
17.14.5 Certifications
17.15 PerSys Medical
17.15.1 Financial Analysis
17.15.2 Product Portfolio
17.15.3 Demographic Reach and Achievements
17.15.4 Mergers and Acquisitions
17.15.5 Certifications
List not exhaustive
18 Global Rapid Infuser Market – Distribution Model (Additional Insight)
18.1 Overview
18.2 Potential Distributors
18.3 Key Parameters for Distribution Partner Assessment
19 Key Opinion Leaders (KOL) Insights (Additional Insight)
20 Company Competitiveness Analysis (Additional Insight)
20.1 Very Small Companies
20.2 Small Companies
20.3 Mid-Sized Companies
20.4 Large Companies
20.5 Very Large Companies
21 Payment Methods (Additional Insight)
21.1 Government Funded
21.2 Private Insurance
21.3 Out-of-Pocket
*Additional insights provided are customisable as per client requirements.
* The coverage of the Market Landscape section depends on the data availability and may cover a minimum of 80% of the total market. The EMR team strives to make this section as comprehensive as possible.
Key Questions Answered in the Report
The market attained a value of about USD 987.7 million in 2023 driven by the increased surgical site infection cases.
The market is anticipated to grow at a CAGR of 4.2% during the forecast period of 2024-2032 and is likely to reach a market value of USD 1429.9 million by 2032.
The rise in hypothermia cases, expanded utilization of rapid infusers in multiple areas and increasing advancements in technology such as enhanced accuracy are directly contributing the market demand.
The surge in FDA approvals for new products, emphasized at offering improved outcomes is a major market trend. In August 2023, the FDA granted 510(k) regulatory clearance to ICU Medical's Plum Duo infusion pump with LifeShield infusion safety software.
The major regions of the market include North America, Europe, Asia Pacific, Latin America, Middle East, and Africa. North America is currently leading the global market.
Types of infusers in the market include trolley-mounted devices and handheld devices.
Rapid infusers offer single-use and reusable usability.
They find applications in cancer, diabetes, and pediatrics among others.
The end users include hospitals, ambulatory services, and specialty clinics among others.
Key players involved in the market are Becton, Dickinson and Company (BD), B. Braun Melsungen AG, Smiths Medical (A division of Smiths Group), 3M Company, Teleflex Incorporated, Fresenius Kabi AG, Stryker Corporation, Smith Medical, ZOLL Medical Corporation, GE Healthcare, Baxter International Inc., Halyard Health, Ivenix, Inc., AngioDynamics, Inc. and FiPerSys Medical.
Purchase Options 10% off
Call us
Purchase Full Report
Mini Report
$ 2969
$2699
-
Selected Sections, One User
-
Printing Not Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Single User License
$ 5499
$4999
-
All Sections, One User
-
One Print Allowed
-
Email Delivery in PDF
-
Free Limited Customisation -
Post Sales Analyst Support -
50% Discount on Next Update
Five User License
$ 6599
$5999
-
All Sections, Five Users
-
Five Prints Allowed
-
Email Delivery in PDF
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Corporate License
$ 7699
$6999
-
All Sections, Unlimited Users
-
Unlimited Prints Allowed
-
Email Delivery in PDF + Excel
-
Free Limited Customisation
-
Post Sales Analyst Support
-
50% Discount on Next Update
Any Question? Speak With An Analyst
View A Sample
Did You Miss Anything, Ask Now
Why Expert Market Research?
Right People
We are technically excellent, strategic, practical, experienced and efficient; our analysts are hand-picked based on having the right attributes to work successfully and execute projects based on your expectations.
Right Methodology
We leverage our cutting-edge technology, our access to trusted databases, and our knowledge of the current models used in the market to deliver you research solutions that are tailored to your needs and put you ahead of the curve.
Right Price
We deliver in-depth and superior quality research in prices that are reasonable, unmatchable, and shows our understanding of your resource structure. We, additionally, offer attractive discounts on our upcoming reports.
Right Support
Our team of expert analysts are at your beck and call to deliver you optimum results that are customised to meet your precise needs within the specified timeframe and help you form a better understanding of the industry.
NEWSLETTER